ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,415.03
-0.28%
Dow Jones
39,869.38
0.00%
Gold vs US Dollar
2,393.29
0.63%
Brent Oil
83.325
0.14%
Bitcoin
66,243.11
1.54%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Autolus Therapeutics PLC (AUTL) Share Price

AUTL Autolus Therapeutics PLC

4.47
0.40 (9.83%)
Pre Market
Last Updated: 13:58:44
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Autolus Therapeutics PLC NASDAQ:AUTL NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.40 9.83 4.47 4.32 4.50 0.00 0.00  3,286 12:58:44   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 1.7M -208.38M -1.1969 -3.40 708.59M
 Type  Size  Price  Time  Units 
 9 39 4.50 12:59:17 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore AUTL News
17/05/202413:27EDGAR2Form 8-K - Current report
17/05/202412:00GLOBEAutolus Therapeutics Reports First Quarter 2024 Financial Results and Business Updates
14/05/202415:00GLOBEAutolus Therapeutics to Present Three Clinical Data Updates on obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) B-Cell acute lymphoblastic leukemia (ALL) patients at the 2024 European Hematology Association (EHA) Congress
13/05/202414:33EDGAR2Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
13/05/202412:23EDGAR2Form 8-K - Current report
13/05/202412:00GLOBEAutolus Therapeutics Announces Delay to its First Quarter 2024 Earnings Release and Conference Call
24/04/202415:00GLOBEAbstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO
Period
Draw mode
Data Downloads for AUTL

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Autolus Therapeutics PLC Articles